🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 3b, 3-year, open-label, multi-center study in which patient...
Status
Terminated
Location
Advanced Discovery Research, LLC
Start Date
2022-11-08
Trial ID
NCT05643170
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of KarXT +...
Status
Recruiting
Location
Imaging Endpoints
Start Date
2025-07-10
Trial ID
NCT07011732
Treatments Being Tested
A Phase 3, Multicenter, Two-part Study with a 5-week Double-blind Part (Ran...
Status
Completed
Location
Anhui Mental Health Center
Start Date
2023-05-29
Trial ID
NCT05919823
Treatments Being Tested
The goal of the trial is to see if the Safety and Tolerability of X/T+X/T-E...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-01
Trial ID
NCT07212062
Treatments Being Tested
The purpose of this study is to evaluate novel KarX and KarT prototypes ver...
Status
Recruiting
Location
Quotient Sciences
Start Date
2025-06-27
Trial ID
NCT07063342
This is a Phase 3, randomized, double-blind, placebo-controlled, parallel g...
Status
Recruiting
Location
Local Institution - 1116
Start Date
2023-08-28
Trial ID
NCT06126224
This is a Phase 3, multicenter, 56-week, outpatient, open-label (OL) study ...
Status
Completed
Location
Local Institution - 011-238
Start Date
2021-06-02
Trial ID
NCT04820309
Treatments Being Tested
This is a Phase 3, 38-week, randomized, double-blind, placebo-controlled, m...
Status
Recruiting
Location
Local Institution - 1029
Start Date
2022-08-23
Trial ID
NCT05511363
This is a Phase 3, randomized, double-blind, parallel-group, placebo-contro...
Status
Completed
Location
Woodland International Research Group, LLC
Start Date
2020-12-16
Trial ID
NCT04659161
Treatments Being Tested
This is a Phase 3, 6-week, randomized, double-blind, placebo-controlled, mu...
Status
Completed
Location
IMA Clinical Research
Start Date
2021-11-12
Trial ID
NCT05145413
Treatments Being Tested